Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass Spectrometry

被引:120
作者
Whiteaker, Jeffrey R. [1 ]
Zhao, Lei [1 ]
Abbatiello, Susan E. [2 ]
Burgess, Michael [2 ]
Kuhn, Eric [2 ]
Lin, ChenWei [1 ]
Pope, Matthew E. [3 ]
Razavi, Morteza [3 ]
Anderson, N. Leigh [4 ]
Pearson, Terry W. [3 ]
Carr, Steven A. [2 ]
Paulovich, Amanda G. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
[2] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA
[3] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada
[4] Plasma Proteome Inst, Washington, DC 20009 USA
关键词
APOLIPOPROTEIN-A-I; IMMUNOAFFINITY ENRICHMENT; ISOTOPE-DILUTION; ABSOLUTE QUANTIFICATION; BIOMARKER DISCOVERY; MULTIPLEXED ASSAYS; PROTEIN BIOMARKERS; PLASMA; SERUM; VALIDATION;
D O I
10.1074/mcp.M110.005645
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Stable isotope standards and capture by antipeptide antibodies (SISCAPA) couples affinity enrichment of peptides with stable isotope dilution and detection by multiple reaction monitoring mass spectrometry to provide quantitative measurement of peptides as surrogates for their respective proteins. In this report, we describe a feasibility study to determine the success rate for production of suitable antibodies for SISCAPA assays in order to inform strategies for large-scale assay development. A workflow was designed that included a multiplex immunization strategy in which up to five proteotypic peptides from a single protein target were used to immunize individual rabbits. A total of 403 proteotypic tryptic peptides representing 89 protein targets were used as immunogens. Antipeptide antibody titers were measured by ELISA and 220 antipeptide antibodies representing 89 proteins were chosen for affinity purification. These antibodies were characterized with respect to their performance in SISCAPA-multiple reaction monitoring assays using trypsin-digested human plasma matrix. More than half of the assays generated were capable of detecting the target peptide at concentrations of less than 0.5 fmol/mu l in human plasma, corresponding to protein concentrations of less than 100 ng/ml. The strategy of multiplexing five peptide immunogens was successful in generating a working assay for 100% of the targeted proteins in this evaluation study. These results indicate it is feasible for a single laboratory to develop hundreds of assays per year and allow planning for cost-effective generation of SISCAPA assays. Molecular & Cellular Proteomics 10: 10.1074/mcp.M110.005645, 1-10, 2011.
引用
收藏
页数:10
相关论文
共 35 条
[11]   A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing [J].
Chace, DH ;
Kalas, TA .
CLINICAL BIOCHEMISTRY, 2005, 38 (04) :296-309
[12]   Prediction of high-responding peptides for targeted protein assays by mass spectrometry [J].
Fusaro, Vincent A. ;
Mani, D. R. ;
Mesirov, Jill P. ;
Carr, Steven A. .
NATURE BIOTECHNOLOGY, 2009, 27 (02) :190-198
[13]   Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS [J].
Gerber, SA ;
Rush, J ;
Stemman, O ;
Kirschner, MW ;
Gygi, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :6940-6945
[14]   Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry [J].
Hoofnagle, Andrew N. ;
Becker, Jessica O. ;
Wener, Mark H. ;
Heinecke, Jay W. .
CLINICAL CHEMISTRY, 2008, 54 (11) :1796-1804
[15]   Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution [J].
Keshishian, Hasmik ;
Addona, Terri ;
Burgess, Michael ;
Kuhn, Eric ;
Carr, Steven A. .
MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (12) :2212-2229
[16]   Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution [J].
Keshishian, Hasmik ;
Addona, Terri ;
Burgess, Michael ;
Mani, D. R. ;
Shi, Xu ;
Kuhn, Eric ;
Sabatine, Marc S. ;
Gerszten, Robert E. ;
Carr, Steven A. .
MOLECULAR & CELLULAR PROTEOMICS, 2009, 8 (10) :2339-2349
[17]   Characterizing degradation products of peptides containing N-terminal Cys residues by (off-line high-performance liquid chromatography)/matrix-assisted laser desorption/ionization quadrupole time-of-flight measurements [J].
Krokhin, OV ;
Ens, W ;
Standing, KG .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2003, 17 (22) :2528-2534
[18]   Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards [J].
Kuhn, E ;
Wu, J ;
Karl, J ;
Liao, H ;
Zolg, W ;
Guild, B .
PROTEOMICS, 2004, 4 (04) :1175-1186
[19]   Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry [J].
Kuhn, Eric ;
Addona, Terri ;
Keshishian, Hasmik ;
Burgess, Michael ;
Mani, D. R. ;
Lee, Richard T. ;
Sabatine, Marc S. ;
Gerszten, Robert E. ;
Carr, Steven A. .
CLINICAL CHEMISTRY, 2009, 55 (06) :1108-1117
[20]   Selected reaction monitoring for quantitative proteomics: a tutorial [J].
Lange, Vinzenz ;
Picotti, Paola ;
Domon, Bruno ;
Aebersold, Ruedi .
MOLECULAR SYSTEMS BIOLOGY, 2008, 4 (1)